With the progress of high-dimensional datasets and improvement of bioinformatics algorithm (23, 24), large-scale interrogation of gene expression and immune activity in multiple tumor types is now accessible, allowing us to investigate factors that affect CD8+ T cell infiltration and determine their correlation with patients’ survival probability as well as the response to immunotherapy. The gene discussed is CD8A; the disease is neoplasm.